Dr. Ayman Omar Soubani, MD

Dr. Soubani practices at Karmanos Cancer Center in Detroit, Michigan, part of McLaren Health Care.

Dr. Soubani's NPI, 1861439358, was assigned on June 1, 2006. Dr. Soubani holds Michigan license 4301075101.

Dr. Soubani's primary practice is Karmanos Cancer Center, at 4100 John R, Detroit, MI 48201 in Wayne County. The practice phone is (800) 576-6266.

Dr. Soubani's primary practice is Karmanos Cancer Center in Detroit, Michigan, part of McLaren Health Care. Dr. Soubani is also affiliated with DMC Harper University Hospital. The medical group on file is Wayne Health. Dmand AI also links Dr. Soubani to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soubani practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Soubani's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Soubani is licensed in Michigan.

CMS data shows 788 Medicare services from Dr. Soubani across 14 procedure codes in 2024, for 286 Medicare patients. Medicare paid $62,649 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Soubani in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Soubani's median patient age at 68, with 54% women.

In 2024, Dr. Soubani wrote 320 Medicare Part D claims for 66 patients. 27% of them were for generic drugs. CMS names the drug for 251 of them, across 10 drugs with 11 or more claims each, at $367,260 in total drug cost. In 2023, CMS named 254 claims across 10 drugs.

Dr. Soubani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Soubani as offering telehealth.

Dmand AI links 116 papers to Dr. Soubani, published from 2004 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Intensive Care Units, Hematopoietic Stem Cell Transplantation and Hospital Mortality. Dr. Soubani has published most often in Adv Respir Med. Dr. Soubani's most frequent co-authors are Shirish Madhav Gadgeel, MD, Ghulam Saydain, MD and Mohammed M. Uddin.

CMS Open Payments shows 24 general payments to Dr. Soubani from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Abbvie Inc. paid the most, $4,336.